https://pipelinereview.com/Boehringer-Ingelheim-Collaborates-with-CDR-Life-to-Develop-Antibody-Fragment-based-Therapeutics-for-Geographic-Atrophy-a-Leading-Cause-of-Blindness-Worldwide/